Portfolio
TD Vaccines discovers and develops novel vaccines to fight serious bacterial infections. Our R&D effort is devoted to medical advancement and the well-being of mankind.
We have built up a pipeline of clinical and pre-clinical vaccine candidates. Our lead programs are vaccines against bacteria causing Travellers’ Diarrhoea.
The annual global market for the ETEC vaccine is estimated to be worth € 500 million.
